Related references
Note: Only part of the references are listed.Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Incidence and predictors of venous thromboembolism in medically ill hospitalized elderly cancer patients: a prospective observational study
Jeong-Ok Lee et al.
SUPPORTIVE CARE IN CANCER (2019)
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
Ingrid Pabinger et al.
LANCET HAEMATOLOGY (2018)
Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer
H. E. Fuentes et al.
THROMBOSIS RESEARCH (2017)
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial
Alok A. Khorana et al.
THROMBOSIS RESEARCH (2017)
Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study
Hiromitsu Kitayama et al.
BMC CANCER (2017)
Incidence of venous thromboembolism in patients with cancer - A cohort study using linked United Kingdom databases
Alex J. Walker et al.
EUROPEAN JOURNAL OF CANCER (2013)
Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment
Toyomi Satoh et al.
THROMBOSIS RESEARCH (2013)
Venous thromboembolism (VTE) in patients with advanced gastric cancer: An Asian experience
Myoung Joo Kang et al.
EUROPEAN JOURNAL OF CANCER (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines
M. Mandala et al.
ANNALS OF ONCOLOGY (2011)
High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis
Russell A. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer
K. W. Lee et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli et al.
LANCET ONCOLOGY (2009)
Effects of race and ethnicity on the incidence of venous thromboembolism
Richard H. White et al.
THROMBOSIS RESEARCH (2009)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
High incidence of silent venous thromboembolism before treatment in ovarian cancer
T. Satoh et al.
BRITISH JOURNAL OF CANCER (2007)
Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
AA Khorana et al.
CANCER (2005)
Prospective evaluation of health-related quality of life in patients with deep venous thrombosis
SR Kahn et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Deep vein thrombosis in cancer: the scale of the problem and approaches to management
A Falanga et al.
ANNALS OF ONCOLOGY (2005)
Share Paper
